期刊文献+

Research Progress of Radical Treatment of Helicobacter Pylori Based on Drug Sensitivity Test as First-Line Treatment

Research Progress of Radical Treatment of Helicobacter Pylori Based on Drug Sensitivity Test as First-Line Treatment
下载PDF
导出
摘要 Helicobacter pylori (HP) infection is a global problem that affects about half of the world’s population and requires sufficient attention in clinical and scientific work. Due to differences in economic and medical conditions among countries around the world, there is currently no unified treatment plan for anti-HP. In China, empirical quadruple therapy is mainly used. With the abuse of antibiotics, many patients face the problem of secondary eradication after failure, and the resistance rate of HP is gradually increasing. After eradication failure, drug sensitivity cultivation is carried out to choose sensitive antibiotics for treatment. A new strategy is currently needed to address how to improve the eradication rate of HP during the first eradication. This article aims to discuss the first-line treatment plans and research progress for eradicating HP based on drug sensitivity testing before eradication. Compared with traditional empirical therapies, treatment based on drug sensitivity results can effectively improve the eradication rate of HP, and reduce drug resistance rates, and adverse reactions, among other benefits. . Helicobacter pylori (HP) infection is a global problem that affects about half of the world’s population and requires sufficient attention in clinical and scientific work. Due to differences in economic and medical conditions among countries around the world, there is currently no unified treatment plan for anti-HP. In China, empirical quadruple therapy is mainly used. With the abuse of antibiotics, many patients face the problem of secondary eradication after failure, and the resistance rate of HP is gradually increasing. After eradication failure, drug sensitivity cultivation is carried out to choose sensitive antibiotics for treatment. A new strategy is currently needed to address how to improve the eradication rate of HP during the first eradication. This article aims to discuss the first-line treatment plans and research progress for eradicating HP based on drug sensitivity testing before eradication. Compared with traditional empirical therapies, treatment based on drug sensitivity results can effectively improve the eradication rate of HP, and reduce drug resistance rates, and adverse reactions, among other benefits. .
作者 Dong Luo Haidong Zhou Changtai Luo Wei Wang Luchang Chen Wujia Yang Xianqi Qin Song Huang Wenzhao Zhang Jiahou Xu Jihua Wei Dong Luo;Haidong Zhou;Changtai Luo;Wei Wang;Luchang Chen;Wujia Yang;Xianqi Qin;Song Huang;Wenzhao Zhang;Jiahou Xu;Jihua Wei(School of Clinical Medicine, Youjiang Medical University for Nationalities, Baise, China;Department of Sports Medicine, Baidong Hospital Affiliated to Youjiang Medical University for Nationalities, Baise, China.)
出处 《Journal of Biosciences and Medicines》 2024年第8期30-39,共10页 生物科学与医学(英文)
关键词 Drug Susceptibility Test Helicobacter Pylori (HP) Infection First-Line Treatment HP Culture Drug Susceptibility Test Helicobacter Pylori (HP) Infection First-Line Treatment HP Culture
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部